nach oben

Erschienen in:

01.06.2014 | original article

Evaluation of oxidant and antioxidant status and relation with prolidase in systemic sclerosis

verfasst von: Esen Savas, MD, Nur Aksoy, Yavuz Pehlivan, Zeynel Abidin Sayiner, Zeynel Abidin Öztürk, Suzan Tabur, Mustafa Örkmez, Ahmet Mesut Onat

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 11-12/2014

Einloggen, um Zugang zu erhalten

Summary

Purpose

Systemic sclerosis (SSc) is a disease characterized by fibrosis of the skin and organs; it is associated with diffuse fibroproliferative microangiopathy and autoimmune background. The studies have shown that the production of excessive free radicals and increased collagen synthesis by the fibroblasts play an important role in the pathophysiology of SSc. Prolidase is an important marker in collagen turnover. We aimed to compare total oxidant status (TOS), total antioxidant status (TAS), oxidative stress index (OSI), and prolidase levels of SSc patients and healthy controls. We also investigated the relationship between prolidase and oxidative stress.

Methods

A total of 38 SSc patients and 33 healthy volunteers were included in the study. Serum TAS, TOS, and prolidase activity were evaluated in the groups.

Results

It was found that the TOS and OSI levels of patients were higher than those in the control group (P = 0.012 and 0.015, respectively), whereas TAS was not significantly different between groups (P = 0.451). Prolidase activity was lower in patients than in controls (P = 0.008). There was a weak correlation between prolidase and OSI in patients. It was found that TAS was lower by marginal significance in the patients with lung and gastrointestinal tract (GT) involvement than the patients without those (P = 0.067 and 0.059, respectively).

Conclusions

Our data suggest that oxidative stress is increased in SSc. TAS is decreased in patients with lung and GT involvement. These results support that antioxidant treatment may be useful in SSc, especially in patients with lung and GT involvement. Antioxidant treatment may prevent organ involvement in SSc. TAS may be a marker that predicts the risk of involvement of a specific organ. In addition, prolidase may be a marker of SSc.

Vorheriger Artikel Nonalcoholic fatty liver disease: a frequent condition in type 2 diabetic patients

Nächster Artikel Is a complete blood cell count useful in determining the prognosis of pulmonary embolism?

Abraham DJ, Varga J. Scleroderma: from cell and molecular mechanisms to disease models. Trends Immunol. 2005;26:587–95.PubMedCrossRef

Gabrielli A, Svegliati S, Moroncini G, Pomponio G, Santillo M, Avvedimento EV. Oxidative stress and the pathogenesis of scleroderma: the Murrel’s hypothesis revisited. Semin Immunopathol. 2008;30:329–37.PubMedCrossRef

Murrell GAC, Francis MJO, Bromley L. Modulation of fibroblast proliferation by oxygen free radicals. Biochem J. 1990;265:659–65.PubMedCentralPubMed

Hinchcliff M, Varga J. Systemic sclerosis/scleroderma: a treatable multisystem disease. Am Fam Physician. 2008;78:961–8.PubMed

Eckes B, Mauch C, Huppe G, Krieg T. Differential regulation of transcription and transcript stability of pro-alpha 1(I) collagen and fibronectin in activated fibroblasts derived from patients with systemic scleroderma. Biochem J. 1996;315:549–54.PubMedCentralPubMed

Myara I, Charpentier C, Lemonnier A. Minireview: prolidase and prolidase deficiency. Life Sci. 1984;34:1985–98.PubMedCrossRef

Surazynski A, Miltyk W, Palka J, Phang JM. Prolidase-dependent regulation of collagen biosynthesis. Amino Acids. 2008;35:731–8.PubMedCrossRef

Masi AT, Rodnan GP, Medsger TA, Jr, Altman RD, D’Angelo WA, Fries JF, et al. Preliminary criteria for the classification of systemic sclerosis. Arthritis Rheum. 1980;23:581–90.CrossRef

Clements P, Lachenbruch P, Siebold J, White B, Weiner S, Martin R, et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol. 1995;22:1281–5.PubMed

10.

Valentini G, Della Rossa A, Bombardieri S, Bencivelli W, Silman AJ, D’Angelo S, et al. European multicenter study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes. Ann Rheum Dis. 2001;60:592–8.PubMedCentralPubMedCrossRef

11.

Medsger TA, Jr, Silman AJ, Steen VD, Black CM, Akesson A, Bacon PA, et al. A disease severity scale for systemic sclerosis: development and testing. J Rheumatol. 1999;26:2159–67.PubMed

12.

Myara I, Charpentier C, Lemonnier A. Optimal conditions for prolidase assay by praline colorimetric determination: application to iminodipeptiduria. Clin Chim Acta. 1982;125:193–205.PubMedCrossRef

13.

Chinard FP. Photometric estimation of proline and ornithine. J Biol Chem. 1952;199:91–5.PubMed

14.

Erel OA. Novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem. 2004;37:112–9.PubMedCrossRef

15.

Koc S, Aksoy N, Bilinc H, Duygu F, Uysal IO, Ekinci A, et al. Paraoxonase and arylesterase activity and total oxidative/antioxidative status in patients with chronic adenotonsillitis. Int J Pediatr Otorhinolaryngol. 2011;75:1364–7.PubMedCrossRef

16.

Erel OA. New automated colorimetric method for measuring total oxidant status. Clin Biochem. 2005;38:1103–11.PubMedCrossRef

17.

Kosecik M, Erel O, Sevinc E, Selek S. Increased oxidative stress in children exposed to passive smoking. Int J Cardiol. 2005;100:61–4.PubMedCrossRef

18.

Yamamoto T, Katayama I, Nishioka K. Nitric oxide production and inducible nitric oxide synthase expression in systemic sclerosis. J Rheumatol. 1998;25(2):314–7.PubMed

19.

Sambo P, Baroni SS, Luchetti M, Paroncini P, Dusi S, Orlandini G, et al. Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway. Arthritis Rheum. 2001;44(11):2653–64.PubMedCrossRef

20.

Stein CM, Tanner SB, Awad JA, Roberts LJ 2nd, Morrow JD. Evidence of free radical-mediated injury (isoprostane overproduction) in scleroderma. Arthritis Rheum. 1996;39(7):1146–50.PubMedCrossRef

21.

Herrick AL, Matucci CM. The emerging problem of oxidative stress and the role of antioxidants in systemic sclerosis. Clin Exp Rheumatol. 2001;19(1):4–8. Review.PubMed

22.

Simonini G, Pignone A, Generini S, Falcini F, Cerinic MM. Emerging potentials for an antioxidant therapy as a new approach to the treatment of systemic sclerosis. Toxicology. 2000;155(1–3):1–15.PubMed

23.

Tikly M, Channa K, Theodorou P, Gulumian M. Lipid peroxidation and trace elements in systemic sclerosis. Clin Rheumatol. 2006;25(3):320–4.PubMedCrossRef

24.

Kalin R, Righi A, Del Rosso A, Bagchi D, Generini S, Cerinic MM, et al. Activin, a grape seed-derived proanthocyanidin extract, reduces plasma levels of oxidative stress and adhesion molecules (ICAM-1, VCAM-1 and E-selectin) in systemic sclerosis. Free Radic Res. 2002;36(8):819–25.PubMedCrossRef

25.

Ogawa F, Shimizu K, Muroi E, Hara T, Sato S. Increasing levels of serum antioxidant status, total antioxidant power, in systemic sclerosis. Clin Rheumatol. 2011;30:921–5.PubMedCrossRef

26.

Rosato E, Rossi C, Molinaro I, Giovannetti A, Pisarri S, Salsano F. Long-term N-acetylcysteine therapy in systemic sclerosis interstitial lung disease: a retrospective study. Int J Immunopathol Pharmacol. 2011;24(3):727–33.PubMed

27.

Ogawa F, Shimizu K, Hara T, Muroi E, Komura K, Takenaka M, et al. Autoantibody against one of the antioxidant repair enzymes, methionine sulfoxide reductase A, in systemic sclerosis: association with pulmonary fibrosis and vascular damage. Arch Dermatol Res. 2010;302:27–35.PubMedCrossRef

28.

Musellim B, Ikitimur H, Uzun H, Ongen G. The oxidant-antioxidant balance in systemic sclerosis cases with interstitial lung involvement. Rheumatol Int. 2006;27(2):163–7.PubMedCrossRef

29.

Gabriele S, Alberto P, Sergio G, Fernanda F, Marco MC. Emerging potentials for an antioxidant therapy as a new approach to the treatment of systemic sclerosis. Toxicology. 2000;155:1–15.PubMedCrossRef

30.

Denton CP, Bunce TD, Dorado MB, Roberts Z, Wilson H, Howell K. Probucol improves symptoms and reduces lipoprotein oxidation susceptibility in patients with Raynaud’s phenomenon. Rheumatology (Oxford). 1999;38(4):309–15.CrossRef

31.

Ocakci A, Coskun O, Tumkaya L, Kanter M, Gurel A, Hosnuterd M, et al. Beneficial effects of ebselen on corrosive esophageal burns of rats. Int J Pediatr Otorhinolaryngol. 2006;70(1):45–52.PubMedCrossRef

32.

Altindag O, Erel O, Aksoy N, Selek S, Celik H, Karaoglanoglu M. Increased oxidative stress and its relation with collagen metabolism in knee osteoarthritis. Rheumatol Int. 2007;27:339–44.PubMedCrossRef

33.

Yildiz A, Demirbag R, Yilmaz R, Gur M, Altiparmak IH, Akyol S, et al. The association of serum prolidase activity with the presence and severity of coronary artery disease. Coron Artery Dis. 2008;19(5):319–25.PubMedCrossRef

34.

Shrinath M, Walter JH, Haeney M, Couriel J, Lewis M, Herrick A. Prolidase deficiency and systemic lupus erythematosus. Arch Dis Child. 1997;76(5):441–4.PubMedCentralPubMedCrossRef

35.

Langberg H, Skovgaard D, Asp S, Kjaer M. Time pattern of exercise-induced changes in type I collagen turnover after prolonged endurance exercise in humans. Calcif Tissue Int. 2000;67(1):41–4.PubMedCrossRef

Titel: Evaluation of oxidant and antioxidant status and relation with prolidase in systemic sclerosis
verfasst von: Esen Savas, MD
Nur Aksoy
Yavuz Pehlivan
Zeynel Abidin Sayiner
Zeynel Abidin Öztürk
Suzan Tabur
Mustafa Örkmez
Ahmet Mesut Onat
Publikationsdatum: 01.06.2014
Verlag: Springer Vienna
Erschienen in: Wiener klinische Wochenschrift / Ausgabe 11-12/2014
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI: https://doi.org/10.1007/s00508-014-0534-4

Springer Medizin Österreich

Summary

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11-12/2014

Veranstaltungen

ÖGIM Fortbildungsveranstaltungen 2014

Cold antibody autoimmune hemolytic anemia and lymphoproliferative disorders: a retrospective study of 20 patients including clinical, hematological, and molecular findings

Use of self-retaining barbed sutures decreases cold ischemia time in open nephron-sparing surgery

Is a complete blood cell count useful in determining the prognosis of pulmonary embolism?

Unilateral olfactory bulb volume loss due to arteriovenous malformation